Thank you for your interest. We would love to hear from you. Let us know how we may help you. Please complete the following information in order for us to gauge what is important to you, thus enabling us to better engage with you.
The Cancer Immunotherapy Trials Network (CITN) and affiliated Immune Oncology Network (ION) strive to make promising experimental immunotherapies broadly available to people with cancer.
Both networks and the Central Operations and Statistical Center (COSC) are headquartered at the Fred Hutchinson Cancer Research Center.